465 related articles for article (PubMed ID: 29155454)
1. Harnessing the power of regulatory T-cells to control autoimmune diabetes: overview and perspective.
Yu H; Paiva R; Flavell RA
Immunology; 2018 Feb; 153(2):161-170. PubMed ID: 29155454
[TBL] [Abstract][Full Text] [Related]
2. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
[TBL] [Abstract][Full Text] [Related]
3. KLRG1 expression identifies short-lived Foxp3
Kornete M; Mason E; Istomine R; Piccirillo CA
Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
[TBL] [Abstract][Full Text] [Related]
4. Modulation of Gut Microbiota by Low Methoxyl Pectin Attenuates Type 1 Diabetes in Non-obese Diabetic Mice.
Wu C; Pan LL; Niu W; Fang X; Liang W; Li J; Li H; Pan X; Chen W; Zhang H; Lakey JRT; Agerberth B; de Vos P; Sun J
Front Immunol; 2019; 10():1733. PubMed ID: 31417546
[TBL] [Abstract][Full Text] [Related]
5. Harnessing memory adaptive regulatory T cells to control autoimmunity in type 1 diabetes.
Li CR; Baaten BJ; Bradley LM
J Mol Cell Biol; 2012 Feb; 4(1):38-47. PubMed ID: 22116888
[TBL] [Abstract][Full Text] [Related]
6. Tolerogenic nanoparticles inhibit T cell-mediated autoimmunity through SOCS2.
Yeste A; Takenaka MC; Mascanfroni ID; Nadeau M; Kenison JE; Patel B; Tukpah AM; Babon JA; DeNicola M; Kent SC; Pozo D; Quintana FJ
Sci Signal; 2016 Jun; 9(433):ra61. PubMed ID: 27330188
[TBL] [Abstract][Full Text] [Related]
7. Intestinal type 1 regulatory T cells migrate to periphery to suppress diabetogenic T cells and prevent diabetes development.
Yu H; Gagliani N; Ishigame H; Huber S; Zhu S; Esplugues E; Herold KC; Wen L; Flavell RA
Proc Natl Acad Sci U S A; 2017 Sep; 114(39):10443-10448. PubMed ID: 28894001
[TBL] [Abstract][Full Text] [Related]
8. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.
Serr I; Fürst RW; Achenbach P; Scherm MG; Gökmen F; Haupt F; Sedlmeier EM; Knopff A; Shultz L; Willis RA; Ziegler AG; Daniel C
Nat Commun; 2016 Mar; 7():10991. PubMed ID: 26975663
[TBL] [Abstract][Full Text] [Related]
9. Emerging Therapeutic Strategies to Restore Regulatory T Cell Control of Islet Autoimmunity in Type 1 Diabetes.
Volfson-Sedletsky V; Jones A; Hernandez-Escalante J; Dooms H
Front Immunol; 2021; 12():635767. PubMed ID: 33815387
[TBL] [Abstract][Full Text] [Related]
10. Targeting regulatory T cells in the treatment of type 1 diabetes mellitus.
Cabrera SM; Rigby MR; Mirmira RG
Curr Mol Med; 2012 Dec; 12(10):1261-72. PubMed ID: 22709273
[TBL] [Abstract][Full Text] [Related]
11. Reversal of New Onset Type 1 Diabetes by Oral
Mbongue JC; Rawson J; Garcia PA; Gonzalez N; Cobb J; Kandeel F; Ferreri K; Husseiny MI
Front Immunol; 2019; 10():320. PubMed ID: 30863412
[TBL] [Abstract][Full Text] [Related]
12. Proinsulin multi-peptide immunotherapy induces antigen-specific regulatory T cells and limits autoimmunity in a humanized model.
Gibson VB; Nikolic T; Pearce VQ; Demengeot J; Roep BO; Peakman M
Clin Exp Immunol; 2015 Dec; 182(3):251-60. PubMed ID: 26206289
[TBL] [Abstract][Full Text] [Related]
13. The gut microbiota and Type 1 Diabetes.
Gülden E; Wong FS; Wen L
Clin Immunol; 2015 Aug; 159(2):143-53. PubMed ID: 26051037
[TBL] [Abstract][Full Text] [Related]
14. IL-2 therapy in type 1 diabetes: "Trials" and tribulations.
Long SA; Buckner JH; Greenbaum CJ
Clin Immunol; 2013 Dec; 149(3):324-31. PubMed ID: 23499139
[TBL] [Abstract][Full Text] [Related]
15. Complex dietary polysaccharide modulates gut immune function and microbiota, and promotes protection from autoimmune diabetes.
Gudi R; Perez N; Johnson BM; Sofi MH; Brown R; Quan S; Karumuthil-Melethil S; Vasu C
Immunology; 2019 May; 157(1):70-85. PubMed ID: 30712258
[TBL] [Abstract][Full Text] [Related]
16. Promoting Immune Regulation in Type 1 Diabetes Using Low-Dose Interleukin-2.
Dwyer CJ; Ward NC; Pugliese A; Malek TR
Curr Diab Rep; 2016 Jun; 16(6):46. PubMed ID: 27076179
[TBL] [Abstract][Full Text] [Related]
17. Th17 Cells in Type 1 Diabetes: Role in the Pathogenesis and Regulation by Gut Microbiome.
Li Y; Liu Y; Chu CQ
Mediators Inflamm; 2015; 2015():638470. PubMed ID: 26843788
[TBL] [Abstract][Full Text] [Related]
18. Ras inhibition attenuates pancreatic cell death and experimental type 1 diabetes: possible role of regulatory T cells.
Aizman E; Mor A; George J; Kloog Y
Eur J Pharmacol; 2010 Sep; 643(1):139-44. PubMed ID: 20599916
[TBL] [Abstract][Full Text] [Related]
19. Treg vaccination in autoimmune type 1 diabetes.
Serr I; Weigmann B; Franke RK; Daniel C
BioDrugs; 2014 Feb; 28(1):7-16. PubMed ID: 23959795
[TBL] [Abstract][Full Text] [Related]
20. β-cell-specific IL-35 therapy suppresses ongoing autoimmune diabetes in NOD mice.
Manzoor F; Johnson MC; Li C; Samulski RJ; Wang B; Tisch R
Eur J Immunol; 2017 Jan; 47(1):144-154. PubMed ID: 27859048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
